Japan study tour
Release time:
2020-07-22
focuses on improvement, standards, and refinement. altruism
this tour experience
recently visited Japan with the research group and went to Toyota TPS lean practice dojo for training and study. around the theme of lean management, Toyota company and its suppliers and manufacturers in Nagoya, Shizuoka, Tokyo and other places were visited on the spot.
was the reward itinerary arranged by the head goose class. I didn't expect much at the beginning, but with the change of mentality from passive to devotion, my group members and I constantly felt that Japan's development had entered a stage of highly developed civilization. Whether it is economic, political, cultural, or national quality, we have a big gap with them. We must always reflect on ourselves, police and encourage ourselves, learn from Japan's strengths, and solve internal and external problems through continuous learning and improvement, so as to seize the opportunity to achieve better development.
Here, I will share what I have seen, heard, learned and thought during my stay in Japan from the aspects of Japan's economy, culture and lean management of enterprises.
1. face up to the gap between the economic development of the two countries
In 1991 , Japan entered a long-term economic downturn after the bubble economy burst. Many enterprises were deeply trapped in the economic quagmire, including the AVEX company we visited. In these 20 years, China has prospered and developed. Our Chinese people's clothing, food, housing and transportation have been continuously upgraded, and earth-shaking changes have taken place. We can eat and drink every day like the Chinese New Year, but are we really developed?
As early as 1987 , Japan's GDP surpassed the former Soviet Union to become the world's second largest economy, when the domestic market economy was only a few years old? How many years has it been since the farmland was distributed to the household? After 2008 , the GDP between China and Japan began to approach, and after 2010 , China surpassed Japan to become the world's second largest economy. China is indeed developing rapidly, but we cannot compare the current economic development achievements with the long-term downturn of the Japanese economy, so as to blindly and confidently look down on Japan.
The accompanying translators and local tour guides on this trip are all Chinese who have lived in Japan for more than 20 years. Through their introduction and exchange, we will compare what we have seen and heard between China and Japan from time to time, as well as the enterprises of both sides. The accompanying Tian Translator is also a senior management consultant and is often invited to teach for some companies in China. He said, "Japan has a complete social security system, and employees' working hours are stable at 7-8 hours without worrying about education, medical care and housing prices. But every time I go to China to see the working conditions of front-line workers, I feel very sad. " But it is this kind of "sad " that makes more and more Chinese entrepreneurs and executives have a strong and urgent need to change their business management.
Although China's total economic volume has surpassed that of Japan, China's land area is 25 times that of Japan, and its population is more than 10 times that of Japan. Simply put, Japan is the area of Yunnan Province, but I need not say much about Japan's economic influence, and everyone understands it. The advantages of Japan's economy are prominently reflected in three aspects: industrial manufacturing, financial strength and technological advantages, which are the three pillars for Japan to maintain world economic hegemony.
As of 2019 , Japan has a total of 33259 100-year-old enterprises and 8 millennium-old enterprises. Among the world's ,500 companies, Japan has a total of 68 multinational companies on the list, second only to the United States. Toyota, Mitsubishi, Nissan, Sony, Toshiba, Panasonic and other world-renowned companies and brands are all world-renowned for their product technical content and quality excellence. Mr. Tian said that Japanese products rarely have quality problems, let alone fake and shoddy products. Hearing this, I feel a little burnt on my face. Made in Japan seems to be synonymous with brand, technology and quality. What about made in China?
2. attaches importance to the gap in culture and education between the two countries
10 January 9 , Japanese chemist Akira Yoshino won the 2019 Nobel Prize in Chemistry. He is Japan's 27 Nobel Prize winner. The well-known Kyoto University in Japan has produced 15 Nobel Prize winners.
It is said that the Japanese government decided on a scientific plan in 2001 with the slogan "Win 30 Nobel Prize in 50 " . Previously, in the 100-year history of the Nobel Prize, Japan had only 9 winners, but from 2001 to 2019 , Japan had 18 winners. According to the rhythm of one year at a time, "50 years 30 " is almost no suspense.
The frequent Nobel Prize winning of Japanese can let us see the essence through the phenomenon: Japan is not really struggling. The so-called loss of the Japanese economy 118 20 years, in a sense, is definitely the 120 of their scientific and technological innovation 20 years. Whoever has the most advanced technology can dominate the development trend of the industry. The Nobel Prize is a powerful weapon developed by Japan, even a shining blade. During the visit to Dafu Group, I was very shocked by what the narrator said, "The two storage systems we visited last have not yet been put into the market because our customer units still have a lot of manual links, but we are ready to meet the development of the times! " Yes, when we say we must strive to be prepared for the change, our neighbors are ready!
AVEX , we also learned that the company was hit hard by the world financial crisis of 2008 , but there was no layoff as we imagined. Instead, we spent more energy on personnel training and technological innovation. After ten years of sharpening, AVEX production of gearbox spool products occupy the first place in the world, supplied to Toyota, Aisin, BMW and other car companies, as well as many Chinese car companies. Isn't this a retreat?
Japanese yen is a famous Japanese biologist, Ichiya Higuchi on the 140 5000 Japanese yen is a famous Japanese writer, and the person with firm eyes and serious face on the largest denomination 10000 Japanese yen is educator and thinker Yukichi Fukuzawa. There is no general or emperor in the Japanese yen. Through this subtle way, Japan tells the public that scholars must be respected and education must be valued. Only science and education can rejuvenate the country. Japanese university teachers will not worry about being left out or losing their jobs because they have not produced scientific research results for a period of time. In the research process, they are rarely interfered by the government and society, such as assessment and evaluation. Long-term concentration on academic research. Of course, Japan is basically a lifelong career country. Many countries, especially China and the United States, believe that talents can only be valuable if they move, but this statement obviously does not exist in Japan.
The two teachers who did the Toyota TPS
41 years and retired to the second-line training. Director Ishigaki Zhongzheng was originally responsible for the production and management of Land Cruisers in Toyota's own factory, and now Toyota is doing talent training. It is understood that Japanese employees will receive paid pre-job training for 3-12 months before starting their jobs. Toyota's training cycle is 6 months and Mitsubishi's 12 months. These professionally trained employees will be able to adapt to their jobs as soon as they take up their jobs. This established corporate training system in the Japanese workplace is beyond our ability to afford. Although some large state-owned enterprises in China have also begun to do pre-job training, they have not made long-term systematization like Japanese enterprises. Fortunately, Tencent, Ali and Huawei have deeply realized the important task of rejuvenating enterprises and the country through science and education. This year Tencent has awarded 1.5
scientists. It is hoped that more and more young scholars will turn their attention to academic research and devote themselves to scientific research and innovation. This road is very difficult, but someone must go. (To be continued) (Ye Liqing)
More information
The company fully deploys 2018 work
On January 27, the group company held a business analysis meeting to review and summarize the work in 2017, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises reported on the overall work situation in 2017, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2018. Xiang Chongping, deputy general manager of the group company, systematically combed the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the "three reductions and three improvements" and the safety and environmental protection work in 2017. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2017, compared and analyzed the main economic indicators of various industrial sectors, and pointed out that looking for new investment and development projects around strategic objectives, promoting the optimization of organizational structure and post setting, significantly improving the level of information management, improving the ability of fund management and tax planning, achieving certain results in scientific and technological innovation and technological transformation, and strengthening marketing management and market expansion, safety and environmental protection work is basically up to standard, training and talent development have achieved new results and other work highlights; at the same time, it summarizes and reflects on the shortcomings in strategic decision-making, management innovation, performance appraisal, market operation, and talent team building. After analyzing the current macroeconomic situation and the future trends of various related industries, Yu Jianhong informed
2020
07-31
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-30
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-31
Jianfeng Pharmaceutical was rated as a provincial trademark brand demonstration enterprise
On December 28, 2017, Zhejiang Administration for Industry and Commerce announced the list of trademark brand demonstration counties (cities, districts), demonstration towns (streets) and demonstration enterprises in Zhejiang Province in 2017. Jianfeng Pharmaceutical Company was identified as a trademark brand demonstration enterprise, and it was also the only enterprise in Jinhua City to enter the list. Peak Pharmaceutical was established in 1998 and obtained the first registered trademark in 1999. Since then, Jianfeng Pharmaceutical has been actively carrying out brand building in accordance with the requirements of the Trademark Law and other laws and regulations, and has set up an intellectual property department to carry out trademark management, rights protection and other activities; it has established a sound trademark management system, strictly in accordance with the provisions of the Trademark Law to supervise and manage the use of trademarks inside and outside the enterprise, and safeguard the legitimate rights and interests of the enterprise. Establish strategic cooperation with professional institutions, for trademark applications, renewals and other work. In recent years, Jianfeng Pharmaceutical has also explored trademark investment, creating value through intangible assets such as trademarks and brands, promoting efficiency improvement, and further expanding corporate influence; at the same time, it has continuously increased investment in new product research and development and technological transformation, and actively Declare various patents to provide strong support for brand building with technological innovation. According to incomplete statistics, Jianfeng Pharmaceutical and its subsidiaries currently have more than 120 valid trademarks, including 1 well-known trademark in China, 2 well-known trademarks in Zhejiang Province, 5 well-known trademarks in Jinhua City, and 2 overseas registered trademarks; Obtained more than 40 domestic and international patents. Trademark is an important part of intellectual property rights, in the knowledge economy, brand effect is increasingly becoming the leading force of economic development.
2020
07-31
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-31
The company was rated as an advanced unit of the city's focus on talent and love talent.
News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)
2020
07-31